Skip to main content
. 2021 May 1;25(3):251–258. doi: 10.4196/kjpp.2021.25.3.251

Fig. 3. Inhibitory effects of fargesin and eudesmin on β-hexosaminidase activity released from RBL-2H3 cells.

Fig. 3

(A) β-Hexosaminidase activity in the media after the exposure of IgE-antigen (Ag)-stimulated mast cells to 3, 10, 30, and 100 µM fargesin and 10 µM BTP2. (B) The release of β-hexosaminidase in stimulated cells after exposure to 3, 10, 30, and 100 µM eudesmin and 10 µM BTP2. Values are presented as means ± SEM. *p < 0.05, ****p < 0.0001 vs. control (value of β-hexosaminidase release in stimulated cells without administration of constituent compounds).